Literature DB >> 34597589

The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma.

Chloé B Steen1, Bogdan A Luca2, Mohammad S Esfahani3, Armon Azizi4, Brian J Sworder3, Barzin Y Nabet5, David M Kurtz3, Chih Long Liu3, Farnaz Khameneh4, Ranjana H Advani3, Yasodha Natkunam6, June H Myklebust7, Maximilian Diehn5, Andrew J Gentles8, Aaron M Newman9, Ash A Alizadeh10.   

Abstract

Biological heterogeneity in diffuse large B cell lymphoma (DLBCL) is partly driven by cell-of-origin subtypes and associated genomic lesions, but also by diverse cell types and cell states in the tumor microenvironment (TME). However, dissecting these cell states and their clinical relevance at scale remains challenging. Here, we implemented EcoTyper, a machine-learning framework integrating transcriptome deconvolution and single-cell RNA sequencing, to characterize clinically relevant DLBCL cell states and ecosystems. Using this approach, we identified five cell states of malignant B cells that vary in prognostic associations and differentiation status. We also identified striking variation in cell states for 12 other lineages comprising the TME and forming cell state interactions in stereotyped ecosystems. While cell-of-origin subtypes have distinct TME composition, DLBCL ecosystems capture clinical heterogeneity within existing subtypes and extend beyond cell-of-origin and genotypic classes. These results resolve the DLBCL microenvironment at systems-level resolution and identify opportunities for therapeutic targeting (https://ecotyper.stanford.edu/lymphoma).
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CIBERSORTx; DLBCL; EcoTyper; diffuse large B cell lymphoma; digital cytometry; expression deconvolution; lymphoma; tumor ecosystems; tumor immunology; tumor microenvironment

Mesh:

Year:  2021        PMID: 34597589      PMCID: PMC9205168          DOI: 10.1016/j.ccell.2021.08.011

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   38.585


  83 in total

1.  Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing.

Authors:  David M Kurtz; Michael R Green; Scott V Bratman; Florian Scherer; Chih Long Liu; Christian A Kunder; Kazuhiro Takahashi; Cynthia Glover; Colm Keane; Shingo Kihira; Brendan Visser; Jason Callahan; Katherine A Kong; Malek Faham; Karen S Corbelli; David Miklos; Ranjana H Advani; Ronald Levy; Rodney J Hicks; Mark Hertzberg; Robert S Ohgami; Maher K Gandhi; Maximilian Diehn; Ash A Alizadeh
Journal:  Blood       Date:  2015-04-17       Impact factor: 22.113

2.  CellPhoneDB: inferring cell-cell communication from combined expression of multi-subunit ligand-receptor complexes.

Authors:  Mirjana Efremova; Miquel Vento-Tormo; Sarah A Teichmann; Roser Vento-Tormo
Journal:  Nat Protoc       Date:  2020-02-26       Impact factor: 13.491

3.  Phenotype molding of stromal cells in the lung tumor microenvironment.

Authors:  Diether Lambrechts; Els Wauters; Bram Boeckx; Sara Aibar; David Nittner; Oliver Burton; Ayse Bassez; Herbert Decaluwé; Andreas Pircher; Kathleen Van den Eynde; Birgit Weynand; Erik Verbeken; Paul De Leyn; Adrian Liston; Johan Vansteenkiste; Peter Carmeliet; Stein Aerts; Bernard Thienpont
Journal:  Nat Med       Date:  2018-07-09       Impact factor: 53.440

4.  Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib.

Authors:  Kai Sun; Lisbeth A Welniak; Angela Panoskaltsis-Mortari; Matthew J O'Shaughnessy; Haiyan Liu; Isabel Barao; William Riordan; Raquel Sitcheran; Christian Wysocki; Jonathan S Serody; Bruce R Blazar; Thomas J Sayers; William J Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

Review 5.  The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification.

Authors:  Madhu P Menon; Stefania Pittaluga; Elaine S Jaffe
Journal:  Cancer J       Date:  2012 Sep-Oct       Impact factor: 3.360

6.  Genomic Feature Selection by Coverage Design Optimization.

Authors:  Stephen Reid; Aaron M Newman; Maximilian Diehn; Ash A Alizadeh; Robert Tibshirani
Journal:  J Appl Stat       Date:  2018-02-07       Impact factor: 1.404

7.  Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.

Authors:  Bjoern Chapuy; Chip Stewart; Andrew J Dunford; Jaegil Kim; Atanas Kamburov; Robert A Redd; Mike S Lawrence; Margaretha G M Roemer; Amy J Li; Marita Ziepert; Annette M Staiger; Jeremiah A Wala; Matthew D Ducar; Ignaty Leshchiner; Ester Rheinbay; Amaro Taylor-Weiner; Caroline A Coughlin; Julian M Hess; Chandra S Pedamallu; Dimitri Livitz; Daniel Rosebrock; Mara Rosenberg; Adam A Tracy; Heike Horn; Paul van Hummelen; Andrew L Feldman; Brian K Link; Anne J Novak; James R Cerhan; Thomas M Habermann; Reiner Siebert; Andreas Rosenwald; Aaron R Thorner; Matthew L Meyerson; Todd R Golub; Rameen Beroukhim; Gerald G Wulf; German Ott; Scott J Rodig; Stefano Monti; Donna S Neuberg; Markus Loeffler; Michael Pfreundschuh; Lorenz Trümper; Gad Getz; Margaret A Shipp
Journal:  Nat Med       Date:  2018-04-30       Impact factor: 53.440

8.  High-dimensional single cell analysis identifies stem-like cytotoxic CD8+ T cells infiltrating human tumors.

Authors:  Jolanda Brummelman; Emilia M C Mazza; Giorgia Alvisi; Federico S Colombo; Andrea Grilli; Joanna Mikulak; Domenico Mavilio; Marco Alloisio; Francesco Ferrari; Egesta Lopci; Pierluigi Novellis; Giulia Veronesi; Enrico Lugli
Journal:  J Exp Med       Date:  2018-08-28       Impact factor: 14.307

9.  Determining cell type abundance and expression from bulk tissues with digital cytometry.

Authors:  Aaron M Newman; Chloé B Steen; Chih Long Liu; Andrew J Gentles; Aadel A Chaudhuri; Florian Scherer; Michael S Khodadoust; Mohammad S Esfahani; Bogdan A Luca; David Steiner; Maximilian Diehn; Ash A Alizadeh
Journal:  Nat Biotechnol       Date:  2019-05-06       Impact factor: 54.908

10.  TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma.

Authors:  Daisuke Ennishi; Shannon Healy; Ali Bashashati; Saeed Saberi; Christoffer Hother; Anja Mottok; Fong Chun Chan; Lauren Chong; Libin Abraham; Robert Kridel; Merrill Boyle; Barbara Meissner; Tomohiro Aoki; Katsuyoshi Takata; Bruce W Woolcock; Elena Viganò; Michael Gold; Laurie L Molday; Robert S Molday; Adele Telenius; Michael Y Li; Nicole Wretham; Nancy Dos Santos; Mark Wong; Natasja N Viller; Robert A Uger; Gerben Duns; Abigail Baticados; Angel Madero; Brianna N Bristow; Pedro Farinha; Graham W Slack; Susana Ben-Neriah; Daniel Lai; Allen W Zhang; Sohrab Salehi; Hennady P Shulha; Derek S Chiu; Sara Mostafavi; Alina S Gerrie; Da Wei Huang; Christopher Rushton; Diego Villa; Laurie H Sehn; Kerry J Savage; Andrew J Mungall; Andrew P Weng; Marcel B Bally; Ryan D Morin; Gabriela V Cohen Freue; Louis M Staudt; Joseph M Connors; Marco A Marra; Sohrab P Shah; Randy D Gascoyne; David W Scott; Christian Steidl
Journal:  Nat Med       Date:  2020-02-24       Impact factor: 53.440

View more
  16 in total

1.  Tee-ing up a New Follicular Lymphoma Classification System.

Authors:  Ari M Melnick
Journal:  Blood Cancer Discov       Date:  2022-09-06

2.  Single-Cell RNA-Seq and Bulk RNA-Seq Reveal Intratumoral Heterogeneity and Tumor Microenvironment Characteristics in Diffuse Large B-Cell Lymphoma.

Authors:  Yang Zhao; Hui Xu; Mingzhi Zhang; Ling Li
Journal:  Front Genet       Date:  2022-05-04       Impact factor: 4.772

3.  Deciphering the cancer microenvironment from bulk data with EcoTyper.

Authors:  Andrea Rolong; Bob Chen; Ken S Lau
Journal:  Cell       Date:  2021-10-14       Impact factor: 66.850

4.  A T cell resilience model associated with response to immunotherapy in multiple tumor types.

Authors:  Yu Zhang; Trang Vu; Douglas C Palmer; Rigel J Kishton; Lanqi Gong; Jiao Huang; Thanh Nguyen; Zuojia Chen; Cari Smith; Ferenc Livák; Rohit Paul; Chi-Ping Day; Chuan Wu; Glenn Merlino; Kenneth Aldape; Xin-Yuan Guan; Peng Jiang
Journal:  Nat Med       Date:  2022-05-02       Impact factor: 87.241

5.  Editorial: B Cell Non-Hodgkin's Lymphoma & Tumor Microenvironment Crosstalk: An Epigenetic Matter?

Authors:  Y Denizot; M S Braza; R Amin
Journal:  Front Genet       Date:  2022-05-19       Impact factor: 4.772

6.  Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL.

Authors:  Tingting Zhang; Hengqi Liu; Lei Jiao; Zhenzhen Zhang; Jin He; Lanfang Li; Lihua Qiu; Zhengzi Qian; Shiyong Zhou; Wenchen Gong; Bin Meng; Xiubao Ren; Huilai Zhang; Xianhuo Wang
Journal:  J Immunother Cancer       Date:  2022-04       Impact factor: 13.751

Review 7.  Biological and Clinical Implications of Gene-Expression Profiling in Diffuse Large B-Cell Lymphoma: A Proposal for a Targeted BLYM-777 Consortium Panel as Part of a Multilayered Analytical Approach.

Authors:  Fleur A de Groot; Ruben A L de Groen; Anke van den Berg; Patty M Jansen; King H Lam; Pim G N J Mutsaers; Carel J M van Noesel; Martine E D Chamuleau; Wendy B C Stevens; Jessica R Plaça; Rogier Mous; Marie José Kersten; Marjolein M W van der Poel; Thomas Tousseyn; F J Sherida H Woei-A-Jin; Arjan Diepstra; Marcel Nijland; Joost S P Vermaat
Journal:  Cancers (Basel)       Date:  2022-04-07       Impact factor: 6.575

8.  Single-cell profiling-guided combination therapy of c-Fos and histone deacetylase inhibitors in diffuse large B-cell lymphoma.

Authors:  Luqiao Wang; Zijuan Wu; Yi Xia; Xueying Lu; Ji Li; Lei Fan; Chun Qiao; Hairong Qiu; Danling Gu; Wei Xu; Jianyong Li; Hui Jin
Journal:  Clin Transl Med       Date:  2022-05

9.  Fucosylation Promotes Cytolytic Function and Accumulation of NK Cells in B Cell Lymphoma.

Authors:  Xing Tong; Yuhua Ru; Jianhong Fu; Ying Wang; Jinjin Zhu; Yiyang Ding; Fulian Lv; Menglu Yang; Xiya Wei; Chenchen Liu; Xin Liu; Lei Lei; Xiaojin Wu; Lingchuan Guo; Yang Xu; Jie Li; Peng Wu; Huanle Gong; Jia Chen; Depei Wu
Journal:  Front Immunol       Date:  2022-06-15       Impact factor: 8.786

Review 10.  DLBCL 1L-What to Expect beyond R-CHOP?

Authors:  Maike Stegemann; Sophy Denker; Clemens A Schmitt
Journal:  Cancers (Basel)       Date:  2022-03-11       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.